Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Expert Rev Precis Med Drug Dev. 2021;6(1):1–4. doi: 10.1080/23808993.2021.1854611

Figure 1.

Figure 1

(A) The identical twin thought experiment to illustrate why proteomics “sees” more than nucleic acid-only approaches. (B) An integrated multi-omic diagnostic approach to human disease requires proteomics. (C) Example of Proteome-Based Diagnostics and proteomic classification of 3 types of colon cancer metastases (Meta 1–3) that are characterized by unique sets of upregulated proteins.